[{"Assets_0_Q3_USD":10881000.0,"CommonStockSharesOutstanding_0_Q3_shares":35002742.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-8839000.0,"NetIncomeLoss_1_Q3_USD":10785000.0,"NetIncomeLoss_3_Q3_USD":-7825000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":29737632.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":29515700.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29737632.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":28723500.0,"StockholdersEquity_0_Q3_USD":-9676000.0,"EarningsPerShareBasic_1_Q3_USD":0.36,"EarningsPerShareBasic_3_Q3_USD":-0.27,"EarningsPerShareDiluted_1_Q3_USD":-0.24,"EarningsPerShareDiluted_3_Q3_USD":-0.68,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":0.0,"Ticker":"OCGN","CIK":"1372299","name":"HISTOGENICS CORP","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]